Europäische Marktprognose für Sarkopenie-Behandlungen bis 2030 – Regionale Analyse – nach Behandlungstyp (Vitamin-D- und Kalziumpräparat, Proteinpräparat, Vitamin-B12-Präparat und andere) und Vertriebskanal (Apotheken, Einzelhandelskanäle, Online-Kanäle und andere)
Anstieg von Unterernährung und Vitaminmangel bei Erwachsenen beflügelt europäischen Markt für Sarkopenie-Behandlungen
Unterernährung ist einer der Hauptrisikofaktoren für Sarkopenie. Laut WHO waren im Jahr 2021 weltweit etwa 2,3 Milliarden Erwachsene unterernährt, was fast 30 % der Weltbevölkerung entspricht. Unter den gemeldeten Risikofaktoren ist Protein-Energie-Mangel eine häufige Ursache für Sarkopenie. Darüber hinaus ist Vitamin-D-Mangel oder -Insuffizienz positiv mit einem erhöhten Risiko für mehrere Krankheiten wie Krebs, Fettleibigkeit, Herz-Kreislauf-Erkrankungen und Sarkopenie verbunden. Laut den National Institutes of Health (NIH) leiden fast 50 % der Weltbevölkerung an Vitamin-D-Mangel und etwa 1 Milliarde Menschen haben einen Vitamin-D-Mangel.
Überblick über den europäischen Markt für Sarkopenie-Behandlungen
Der europäische Markt für Sarkopenie-Behandlungen ist in Deutschland, Frankreich, Großbritannien, Italien, Spanien und das übrige Europa unterteilt. Europa nimmt auf dem globalen Markt für Sarkopenie-Behandlungen eine bedeutende Position ein und wird im Prognosezeitraum voraussichtlich eine bemerkenswerte CAGR verzeichnen.
Deutschland ist aufgrund seines innovativen Ansatzes im Gesundheitswesen ein attraktiver Markt. Laut Statistischem Bundesamt beliefen sich die Gesundheitsausgaben in diesem Land im Jahr 2021 auf 474 Milliarden US-Dollar. Das Bewusstsein für Sarkopenie und sarkopenische Adipositas (SO) nimmt in alternden Gesellschaften in ganz Deutschland allmählich zu. Sarkopenie und SO sind bei deutschen Männern ab 70 Jahren vergleichsweise selten (<5 %). Daher treibt ein Anstieg der Fälle orthopädischer Erkrankungen, gepaart mit der steigenden Nachfrage nach Nahrungsergänzungsmitteln, das Wachstum des Marktes für Sarkopeniebehandlungen in Deutschland voran.
Umsatz und Prognose des europäischen Marktes für Sarkopeniebehandlungen bis 2030 (Mio. USD)
Segmentierung des europäischen Marktes für Sarkopeniebehandlungen
Der europäische Markt für Sarkopeniebehandlungen ist nach Behandlungsart, Vertriebskanal und Land kategorisiert.
Basierend auf der Behandlungsart ist der europäische Markt für Sarkopeniebehandlungen in Vitamin-D- und Kalziumpräparate, Proteinpräparate, Vitamin-B12-Präparate und andere segmentiert. Das Segment der Vitamin-D- und Kalziumpräparate hatte 2022 den größten Marktanteil für Sarkopeniebehandlungen in Europa.
In Bezug auf die Vertriebskanäle ist der europäische Markt für Sarkopeniebehandlungen in Apotheken, Einzelhandelskanäle, Online-Kanäle und andere segmentiert. Das Apothekensegment hatte 2022 den größten Marktanteil bei der Behandlung von Sarkopenie in Europa.
Nach Ländern ist der europäische Markt für die Behandlung von Sarkopenie in Deutschland, Frankreich, Italien, Großbritannien, Spanien und das übrige Europa unterteilt. Deutschland dominierte 2022 den europäischen Marktanteil bei der Behandlung von Sarkopenie.
Abbott Laboratories, Amway Corp, Bayer AG, GSK Plc, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc und Sanofi SA sind einige der führenden Unternehmen auf dem europäischen Markt für die Behandlung von Sarkopenie.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Sarcopenia Treatment Market - Key Industry Dynamics
4.1 Europe Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - Europe Market Analysis
5.1 Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 Europe Sarcopenia Treatment Market Forecast and Analysis
6. Europe Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Europe Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Europe Sarcopenia Treatment Market - Country Analysis
8.1 Europe
8.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Metagenics LLC
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Nestle Health Science SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Novartis AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Pfizer Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Sanofi SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Amway Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 GSK Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Europe Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 14. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 15. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 16. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 17. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 18. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 21. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. Europe Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. Europe Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Europe Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Europe Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 20. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 21. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 22. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Amway Corp
3. Bayer AG
4. GSK Plc
5. Metagenics LLC
6. Nestle Health Science SA
7. Novartis AG
8. Pfizer Inc
9. Sanofi SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.